[fcb5af]: / literature / by_gene / POU2AF1.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 34162177 10.3324/haematol.2020.267096 2022 Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma. POU2AF1
2 33512466 10.1182/blood.2020010175 2021 OBF1 and Oct factors control the germinal center transcriptional program. POU2AF1
3 29931583 10.1007/s10637-018-0623-8 2020 Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2. POU2AF1
4 33232656 10.1016/j.molcel.2020.10.036 2020 Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage. POU2AF1
5 29375549 10.3389/fimmu.2017.01841 2019 Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome. POU2AF1
6 30802265 10.1371/journal.pone.0212813 2019 Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma. POU2AF1
7 27835906 10.18632/oncotarget.13239 2018 Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma. POU2AF1
8 28756244 10.1016/j.imlet.2017.07.012 2018 High frequency of Bob1<sup>lo</sup> T follicular helper cells in florid reactive follicular hyperplasia. POU2AF1
9 27229929 10.1186/s12885-016-2374-2 2017 Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor. POU2AF1
10 27319306 10.1111/his.13017 2017 Oct2 and Bob1 are sensitive and specific markers in lineage determination of B cell lymphomas with no expression of conventional B cell markers. POU2AF1
11 28053195 10.1182/blood-2016-09-737536 2017 TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1. POU2AF1
12 28064239 10.1182/blood-2016-07-729954 2017 Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. POU2AF1
13 28345816 10.1002/mc.22652 2017 Germline variation in the 3'-untranslated region of the POU2AF1 gene is associated with susceptibility to lymphoma. POU2AF1
14 28851661 10.1016/j.humpath.2017.08.015 2017 J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. POU2AF1
15 24300721 10.1097/PAT.0000000000000039 2015 Plasmablastic lymphoma presenting as a colonic stricture in Crohn's disease. POU2AF1
16 24115831 10.3748/wjg.v19.i37.6299 2014 A case of plasmablastic lymphoma of the liver without human immunodeficiency virus infection. POU2AF1
17 24332044 10.1016/j.ccr.2013.11.003 2014 Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. POU2AF1
18 22324490 10.1111/j.1600-0560.2012.01872.x 2012 Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators. POU2AF1
19 21420167 10.1016/j.leukres.2010.10.032 2011 Chromosome 11q23.1 is an unstable region in B-cell tumor cell lines. POU2AF1
20 21424034 2011 B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma. POU2AF1
21 21438833 10.3109/10428194.2010.548535 2011 Expression and prognostic significance of Oct2 and Bob1 in multiple myeloma: implications for targeted therapeutics. POU2AF1
22 17822631 2010 [Differential diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma and lymphocyte-rich classic Hodgkin lymphoma: role of immunohistochemistry]. POU2AF1
23 20102401 10.1111/j.1365-2559.2009.03462.x 2010 BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma. POU2AF1
24 20141429 10.3109/10428191003592735 2010 OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed acute myeloid leukemia. POU2AF1
25 18695675 10.1038/onc.2008.286 2008 Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells. POU2AF1
26 16648862 10.1038/modpathol.3800622 2007 Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays. POU2AF1
27 17562619 10.1532/IJH97.06094 2007 Primary gastric Hodgkin's lymphoma expressing a B-Cell profile including Oct-2 and Bob-1 proteins. POU2AF1
28 17577776 10.1080/10428190701342000 2007 Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma. POU2AF1
29 16186795 10.1038/sj.onc.1209127 2006 Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression. POU2AF1
30 16778825 10.1038/modpathol.3800650 2006 Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma. POU2AF1
31 15257313 10.1038/modpathol.3800227 2005 Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma. POU2AF1
32 15672409 10.1002/gcc.20159 2005 Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia. POU2AF1
33 15796964 10.1016/j.cancergencyto.2004.09.005 2005 Alterations of loci encoding PU.1, BOB1, and OCT2 transcription regulators do not correlate with their suppressed expression in Hodgkin lymphoma. POU2AF1
34 16249468 10.1167/iovs.05-0318 2005 Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma. POU2AF1
35 12848851 10.1046/j.0818-9641.2003.01172.x 2004 Knockout B lymphoma cell lines as biochemical tools to explore multiple signalling pathways. POU2AF1
36 14662861 10.4049/jimmunol.171.12.6589 2004 Critical role for the Oct-2/OCA-B partnership in Ig-secreting cells. POU2AF1
37 14694522 10.1002/path.1485 2004 Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. POU2AF1
38 15231650 10.1158/0008-5472.CAN-03-3885 2004 High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. POU2AF1
39 15284123 10.1182/blood-2003-04-1197 2004 Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. POU2AF1
40 12507907 10.1016/s0002-9440(10)63815-1 2003 Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. POU2AF1
41 12592383 10.1038/sj.onc.1206270 2003 Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. POU2AF1
42 12647220 10.1007/s00428-002-0735-5 2003 Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma. POU2AF1
43 14608905 10.1309/YCH8-DWUF-FQBK-GPVB 2003 The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. POU2AF1
44 11904338 10.1038/modpathol.3880518 2002 Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas. POU2AF1
45 11929801 10.1182/blood.v99.8.3060 2002 Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. POU2AF1
46 11154228 10.1182/blood.v97.2.496 2001 Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. POU2AF1
47 11280769 2001 Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. POU2AF1
48 11342448 10.1182/blood.v97.10.3191 2001 Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. POU2AF1
49 10666379 10.1016/S0002-9440(10)64754-2 2000 Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas. POU2AF1
50 9724642 10.1093/emboj/17.17.5066 1998 OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development. POU2AF1
51 8574789 1996 Fusion of the LAZ3/BCL6 and BOB1/OBF1 genes by t(3; 11) (q27; q23) chromosomal translocation. POU2AF1
52 8618432 1996 The B cell transcriptional coactivator BOB1/OBF1 gene fuses to the LAZ3/BCL6 gene by t(3;11)(q27;q23.1) chromosomal translocation in a B cell leukemia line (Karpas 231). POU2AF1
53 8751468 1996 Heterogeneity of breakpoints at the transcriptional co-activator gene, BOB-1, in lymphoproliferative disease. POU2AF1